Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;39(6):e22152.
doi: 10.1002/jca.22152.

An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee

Affiliations
Review

An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee

Yvette C Tanhehco et al. J Clin Apher. 2024 Dec.

Abstract

In this first annual review article, the American Society for Apheresis (ASFA) Attending Physician Subcommittee (APSc) of the Physicians' Committee (PC) curated key apheresis literature in 2023 and presented their choices for the 10 most seminal apheresis articles. PubMed and OVID search engines were used to identify manuscripts from four topic areas: donor apheresis, therapeutic apheresis, education, and cellular therapy. To further identify seminal criteria, they had to present at least one of the following: novel findings, practice-altering outcomes, international scope, randomized controlled trial, relevant to current clinical practice, and/or provide evidence for category III or IV indications based on the ASFA ninth special issue of the Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach. Inclusion criteria included: full-length, peer-reviewed, English language, and human subjects. Case reports, review articles, and meta-analyses were excluded.

Keywords: apheresis education; cell therapy; donor apheresis; stem cell collection; therapeutic apheresis.

PubMed Disclaimer

References

    1. L. Connelly‐Smith, C. R. Alquist, N. A. Aqui, et al., “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach From the Writing Committee of the American Society for Apheresis: The Ninth Special Issue,” Journal of Clinical Apheresis 38, no. 2 (2023): 77–278.
    1. K. B. Miller, T. F. Roberts, G. Chan, et al., “A Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation Associated With a Reduced Incidence of Graft‐Versus‐Host Disease,” Bone Marrow Transplantation 33, no. 9 (2004): 881–889.
    1. P. J. Shaughnessy, B. J. Bolwell, K. van Besien, et al., “Extracorporeal Photopheresis for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation,” Bone Marrow Transplantation 45, no. 6 (2010): 1068–1076.
    1. C. L. Kitko, T. Braun, D. R. Couriel, et al., “Combination Therapy for Graft‐Versus‐Host Disease Prophylaxis With Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial,” Biology of Blood and Marrow Transplantation 22, no. 5 (2016): 862–868.
    1. S. H. Abhyankar, T. M. Yankee, D. S. Warhadpande, et al., “The Addition of Extracorporeal Photophoresis (ECP) to Tacrolimus and Methotrexate to Prevent Acute and Chronic Graft‐Versus Host Disease (aGvHD, cGvHD) in Patients Undergoing a Myeloablative (MA) Hematopoietic Cell Transplant (HCT),” Biology of Blood and Marrow Transplantation 20 (2014): S212–S213.

LinkOut - more resources